VOLITIONRX LTD — Director's Dealing 2022

Dec 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-12-19-05:00

Reporting Person: Butera Salvatore Thomas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-19-05:00	Common Stock	P	5000	$2.27	Acquired	51350	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	146200	Direct

Footnotes

F1: These shares of common stock are jointly owned by the reporting person and his spouse.